Increased number of CD25+ FoxP3+ regulatory T cells in oral squamous cell carcinomas detected by chromogenic immunohistochemical double staining

Journal of Oral Pathology and Medicine

Volumn 37, Issue 8, 2008, Pages 485-489

  Schwarz, Stephan ^a   Butz, Martin ^b   Morsczeck, Christian ^b   Reichert, Torsten E ^b   Driemel, Oliver ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

CD25+ FoxP3+ regulatory T cells; Double staining; Immunohistochemistry; Oral squamous cell carcinoma

Indexed keywords

CD3 ANTIGEN; TRANSCRIPTION FACTOR FOXP3;

ARTICLE; CANCER STAGING; CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SQUAMOUS CELL CARCINOMA; TONSIL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR BIOPSY;

ANTIGENS, CD3; ANTIGENS, CD4; BIOPSY; CARCINOMA, SQUAMOUS CELL; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; CHROMOGENIC COMPOUNDS; COLORING AGENTS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MOUTH NEOPLASMS; NEOPLASM STAGING; PALATINE TONSIL; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 49249098896     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2008.00641.x     Document Type: Article

References (22)

1. Gallegos-Hernandez JF. Head and neck cancer. Risk factors and prevention. Cir Cir 2006 74 : 287 93.
2. Reichert TE, Strauss L, Wagner EM, Gooding W, Whiteside TL. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma. Clin Cancer Res 2002 8 : 3137 45.
3. Ogino T, Bandoh N, Hayashi T, Miyokawa N, Harabuchi Y, Ferrone S. Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patients. Clin Cancer Res 2003 9 : 4043 51.
4. + T-cell subpopulations in head and neck cancers. Clin Cancer Res 2006 12 : 465 72.
5. Carrier Y, Yuan J, Kuchroo VK, Weiner HL. Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice. J Immunol 2007 178 : 179 85.
6. + T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001 193 : 1285 94.
7. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995 155 : 1151 64.
8. + suppressor T cells: more questions than answers. Nat Rev Immunol 2002 2 : 389 400.
9. Bennett CL, Christie J, Ramsdell F, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001 27 : 20 1.
10. + regulatory T-cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative. Eur J Immunol 2004 34 : 336 44.
11. Liyanage UK, Moore TT, Joo HG, et al. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 2002 169 : 2756 61.
12. Wolf AM, Wolf D, Steurer M, et al. Increase of regulatory T cells in the peripheral blood of cancer patients. Clin Cancer Res 2003 9 : 606 12.
13. Miyara M, Sakagucki S. Natural regulatory T cells: mechanisms of suppression. Trends Mol Med 2007 13 : 108 16.
14. + T cells secreting interleukin-10 and transforming growth factor-β1 mediates suppression in the tumor microenvironment. Clin Cancer Res 2007 13 : 4345 54.
15. + T-cell activation and high viral load. J Virol 2007 81 : 13444 55.
16. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004 22 : 531 62.
17. + regulatory T cells into chronically inflamed intestine. Gastroenterology 2007 132 : 966 81.
18. + regulatory T cells at the single-cell level. Eur J Immunol 2005 35 : 1681 91.
19. Gavin MA, Torgerson TR, Houston E, et al. Single-cell analysis of normal and FoxP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci USA 2006 103 : 6659 64.
20. + regulatory T cells in the peripheral circulation of patients with head and neck cancer. Br J Cancer 2005 92 : 913 20.
21. Fu J, Xu D, Liu Z, et al. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Gastroenterology 2007 132 : 2328 39.
22. + T cells in the circulation of patients with head and neck squamous cell carcinoma (HNSCC) and correlation with advanced disease. Arch Otolaryngol Head Neck Surg 2006 132 : 883 4.